By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Beximco Pharmaceuticals Limited

Beximco Pharmaceuticals Limited (BXP.L)

LSE Market Data in GBP, Fundamentals in BDT
£39.50
+£1.00
+2.60%
Last Update: 16 Jul 2025, 15:35
£176.21M
Market Cap
0.00
P/E Ratio (TTM)
8.48%
Forward Dividend Yield
£19.33 - £41.00
52 Week Range

BXP.L Stock Price Chart

Explore Beximco Pharmaceuticals Limited interactive price chart. Choose custom timeframes to analyze BXP.L price movements and trends.

There is nothing to show.

BXP.L Company Profile

Discover essential business fundamentals and corporate details for Beximco Pharmaceuticals Limited (BXP.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

21 Oct 2005

Employees

6.00K

CEO

Iqbal U. Ahmed

Description

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

BXP.L Financial Timeline

Browse a chronological timeline of Beximco Pharmaceuticals Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 27 Jan 2026

Upcoming earnings on 12 Nov 2025

Earnings released on 3 Jun 2025

Earnings released on 28 Jan 2025

EPS came in at £0.03, while revenue for the quarter reached £81.82M.

Dividend declared on 22 Nov 2024

A dividend of £3.35 per share was announced, adjusted to £3.35. The dividend was paid on 6 Feb 2025.

Earnings released on 7 Nov 2024

Earnings released on 30 Jun 2024

EPS came in at £0.02, while revenue for the quarter reached £76.21M.

Earnings released on 30 Apr 2024

EPS came in at £0.02, while revenue for the quarter reached £79.52M, missing expectations by -69.05%.

Earnings released on 30 Jan 2024

EPS came in at £0.02, while revenue for the quarter reached £79.17M, beating expectations by +1.02%.

Dividend declared on 10 Nov 2023

A dividend of £3.17 per share was announced, adjusted to £3.17. The dividend was paid on 8 Feb 2024.

Earnings released on 30 Sept 2023

EPS came in at £0.03, while revenue for the quarter reached £83.03M.

Earnings released on 30 Jun 2023

EPS came in at £0.02, while revenue for the quarter reached £72.77M.

Earnings released on 31 Mar 2023

EPS came in at £0.02, while revenue for the quarter reached £72.22M.

Earnings released on 31 Dec 2022

EPS came in at £0.02, while revenue for the quarter reached £80.43M.

Dividend declared on 17 Nov 2022

A dividend of £3.32 per share was announced, adjusted to £3.32. The dividend was paid on 27 Mar 2023.

Earnings released on 30 Sept 2022

EPS came in at £0.03, while revenue for the quarter reached £87.02M.

Earnings released on 30 Jun 2022

EPS came in at £0.02, while revenue for the quarter reached £76.81M.

Earnings released on 31 Mar 2022

EPS came in at £0.02, while revenue for the quarter reached £79.98M.

Earnings released on 31 Dec 2021

EPS came in at £0.03, while revenue for the quarter reached £73.80M.

Dividend declared on 18 Nov 2021

A dividend of £3.97 per share was announced, adjusted to £3.97. The dividend was paid on 15 Feb 2022.

Earnings released on 30 Sept 2021

EPS came in at £0.03, while revenue for the quarter reached £73.56M.

Earnings released on 30 Jun 2021

EPS came in at £0.03, while revenue for the quarter reached £65.73M.

Earnings released on 31 Mar 2021

EPS came in at £0.03, while revenue for the quarter reached £62.63M.

Earnings released on 31 Dec 2020

EPS came in at £0.02, while revenue for the quarter reached £64.74M.

Dividend declared on 23 Nov 2020

A dividend of £1.77 per share was announced, adjusted to £1.77. The dividend was paid on 27 Jan 2021.

Stock split effective on 23 Nov 2020

Shares were split 11:10, changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Sept 2020

EPS came in at £0.02, while revenue for the quarter reached £63.03M.

BXP.L Stock Performance

Access detailed BXP.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
BXP.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
BXP.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More